USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abiochem Biotechnology (group) Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, active 2022–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).

6
Total patents granted
8
CPC technology areas
6.7
Avg claims per patent
-
5-year filing velocity

The verdict

Abiochem holds 6 US patents across 8 technology areas, rank #38,524 of 50,000 tracked assignees.

#38,524
of 50,000 US assignees by volume
Top 35%
by Innovation Score (40.7/100)
6.7
avg claims per patent

Portfolio overview

Abiochem Biotechnology (group) Co., Ltd. has been granted 6 US utility patents between 2022 and 2024, placing Abiochem Biotechnology (group) Co., Ltd. at rank #38,524 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.7 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a Foreign Corporation, Abiochem Biotechnology (group) Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Abiochem sits between Abaco Systems, Inc. (6 patents, rank #38,520) and ABP Induction Systems Gmbh (6 patents, rank #38,528) - the closest US assignees by grant volume. The composite Innovation Score of 40.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2024, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abiochem Biotechnology (group) Co., Ltd.'s 6.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abiochem Biotechnology (group) Co., Ltd. against peers pursuing similar technology classes.

Who files at Abiochem's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Abiochem holds 6 patents at rank #38,524, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Abiochem

By rank, the assignees closest to #38,524 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Abiochem's primary technology class.

Abiochem's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 202220232024 2
USPTO utility patent grants by year · 2022–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Abiochem Biotechnology (group) Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 3 50.0%
2023 1 16.7%
2024 2 33.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple

Where it ranks

Overall rank by patents

#38,524

Across all tracked assignees

Innovation Score

40.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abiochem Biotechnology (group) Co., Ltd. hold?
Abiochem Biotechnology (group) Co., Ltd. holds 6 US granted patents filed between 2022 and 2024, spanning 8 technology areas.
What is Abiochem Biotechnology (group) Co., Ltd.'s Innovation Score?
Abiochem Biotechnology (group) Co., Ltd. has an Innovation Score of 40.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Abiochem Biotechnology (group) Co., Ltd. focus on?
Abiochem Biotechnology (group) Co., Ltd.'s top technology area is C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE) with 6 patents. The company has filed patents in 8 CPC subclasses total.
Is Abiochem Biotechnology (group) Co., Ltd.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Abiochem Biotechnology (group) Co., Ltd..
What does claim depth mean for Abiochem Biotechnology (group) Co., Ltd.'s patents?
Abiochem Biotechnology (group) Co., Ltd.'s patents average 6.7 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Abiochem Biotechnology (group) Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abiochem's 6 grants land it in the top 35% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Abiochem ranks #38,524 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12P - see who else leads that technology area. C12P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.